Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study

Fig. 2

Paclitaxel (PTX) sensitivity of human amniotic mesenchymal stromal cells (hAMSCs). a Twenty-four-hour cytotoxicity assay of hAMSCs in the presence of PTX. Bars represent mean value ± SD for five donors. b Seven-day anti-proliferation assay of hAMSCs (seven donors) in the presence of 10-fold serial dilutions of PTX (linear regression analysis). c Paclitaxel half maximal inhibitory concentration (IC 50 ) values (expressed as ng/ml) assessed by linear regression analysis in the anti-proliferation assay. For each donor, the mean value ± SD of at least two independent experiments is reported. The analysis of IC50 values by a multiple comparison test showed that only the IC50 of donor 5 is significantly different from mean value (*)

Back to article page